<p>直觉外科（NASDAQ:ISRG - 获取免费报告）在华尔街 Zen 的股票研究分析师的研究报告中，将其评级从 “持有” 上调至 “买入”。</p>
<p>获取 <strong>Intuitive Surgical</strong> 的提醒：</p>
<ul>
<li>Intuitive Surgical 的抛售为 30% 的反弹机会铺平了道路</li>
</ul>
<p>其他一些分析师最近也对 ISRG 发布了报告。Evercore 将 Intuitive Surgical 的目标价从 550.00 美元下调至 480.00 美元，并在 4 月 6 日的研究报告中给予该公司 “中性” 评级。Barclays 在 4 月 23 日的研究报告中将 Intuitive Surgical 的目标价设定为 651.00 美元，并给予该公司 “增持” 评级。Robert W. Baird 在 4 月 22 日的报告中将 Intuitive Surgical 的目标价从 575.00 美元上调至 610.00 美元，并给予该公司 “跑赢大盘” 评级。Jefferies Financial Group 在 4 月 22 日的报告中将 Intuitive Surgical 的目标价从 560.00 美元下调至 515.00 美元，并对该股票给予 “持有” 评级。最后，BTIG Research 在 4 月 22 日的报告中重申了 “买入” 评级，并将 Intuitive Surgical 的目标价设定为 574.00 美元。共有 18 位股票研究分析师对该股票给予了买入评级，7 位给予了持有评级，1 位给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 581.91 美元。</p>
<p><strong>查看我们关于 Intuitive Surgical 的最新股票报告</strong></p>
<h2>Intuitive Surgical 股价下跌 1.6%</h2>
<ul>
<li>5 只股票在 AI 超级推动下快速上涨</li>
</ul>
<p>ISRG 周五开盘价为 421.12 美元。该股票的市值为 1491.4 亿美元，市盈率为 51.04，PEG 比率为 3.42，贝塔系数为 1.51。Intuitive Surgical 的一年低点为 417.74 美元，一年高点为 603.88 美元。该股票的 50 日移动平均价格为 463.63 美元，200 日移动平均价格为 514.04 美元。</p>
<p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近于 4 月 21 日发布了季度财报。该医疗设备提供商报告每股收益（EPS）为 2.50 美元，超出分析师共识预期的 2.08 美元，超出幅度为 0.42 美元。该公司在本季度的收入为 27.7 亿美元，而分析师预期为 26.2 亿美元。Intuitive Surgical 的股本回报率为 15.98%，净利润率为 28.15%。该公司的季度收入同比增长 23.0%。去年同期，该公司每股收益为 1.81 美元。作为一个整体，卖方分析师预测 Intuitive Surgical 在当前财政年度将发布 8.57 美元的每股收益。</p>
<h2>Intuitive Surgical 的内部活动</h2>
<ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股票</li>
</ul>
<p>在其他 Intuitive Surgical 的新闻中，执行副总裁 Gary Loeb 于 5 月 11 日星期一出售了 400 股该公司的股票。股票以平均价格 446.95 美元出售，总交易额为 178,780.00 美元。交易后，该执行副总裁直接持有该公司 6,120 股，价值 2,735,334 美元。此交易代表其持股比例减少了 6.13%。该交易已在证券交易委员会的备案中披露，相关信息可在 SEC 网站上查阅。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，资深副总裁 Mark Brosius 于 3 月 4 日星期三出售了 2,362 股该公司的股票。股票以平均价格 498.68 美元出售，总价值为 1,177,882.16 美元。交易后，资深副总裁持有该公司 3,554 股，价值约 1,772,308.72 美元。此交易代表其持股比例减少了 39.93%。有关此销售的更多详细信息可在官方 SEC 披露中找到。在过去一个季度中，内部人士出售了价值 2,760,359 美元的 5,647 股公司股票。内部人士持有该公司股票的 0.60%。</p>
<h2>对 Intuitive Surgical 的对冲基金看法</h2>
<p>一些机构投资者最近对该公司的持仓进行了调整。Gateway Wealth Partners LLC 在第一季度购买了 Intuitive Surgical 的新股份，价值约 409,000 美元。Blue Chip Partners LLC 在第一季度将其在 Intuitive Surgical 的股份增加了 6.0%。Blue Chip Partners LLC 目前持有该医疗设备提供商的 2,274 股股票，价值 1,048,000 美元，此前在该期间内又购买了 129 股。Weiss Asset Management LP 在第一季度购买了 Intuitive Surgical 的新股份，价值约 5,808,000 美元。OMERS ADMINISTRATION Corp 在第一季度将其在 Intuitive Surgical 的股份增加了 98.4%。OMERS ADMINISTRATION Corp 目前持有该医疗设备提供商的 289,024 股股票，价值 133,237,000 美元，此前在该期间内又购买了 143,345 股。最后，Bradley Foster &amp; Sargent Inc. CT 在第一季度将其在 Intuitive Surgical 的股份增加了 3.7%。Bradley Foster &amp; Sargent Inc. CT 目前持有该医疗设备提供商的 50,697 股股票，价值 23,371,000 美元，此前在该期间内又购买了 1,797 股。83.64% 的股票目前由机构投资者持有。</p>
<h2>影响 Intuitive Surgical 的关键故事</h2>
<p>以下是本周影响 Intuitive Surgical 的关键新闻故事：</p>
<ul>
<li>积极情绪：多篇近期文章强调了直觉外科（Intuitive Surgical）作为医疗保健领域人工智能浪潮的潜在受益者，认为每一次机器人手术都会产生有价值的数据，从而改善外科医生培训、术中指导和预测分析。手术机器人与人工智能的结合：直觉外科、美敦力（Medtronic）和史崔克（Stryker）是医疗保健繁荣的潜在黑马。</li>
<li>积极情绪：Erste Group Bank 的分析师上调了对 ISRG 的 2026 财年和 2027 财年的盈利预期，强化了盈利增长能够持续超过市场共识的预期。MarketBeat 对 ISRG 的覆盖。</li>
<li>积极情绪：关于达芬奇 5（da Vinci 5）的报道指出手术增长强劲，系统利用率提高，表明该公司的最新平台仍在外科医生和医院中获得认可。ISRG 的达芬奇 5 能否维持手术和利用率的增长？</li>
<li>中性情绪：几篇乐观的评论文章表示，近期的抛售使得直觉外科对成长型投资者更具吸引力，但这些主要是评论而非新的公司特定催化剂。直觉外科今年已下跌 20%。华尔街表示，现在是买入的时机。</li>
</ul>
<h2>直觉外科公司简介</h2>
<p>(获取免费报告)</p>
<p>直觉外科成立于 1995 年，总部位于加利福尼亚州阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗技术公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉的业务集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室的精确度、可视化和控制能力。</p>
<p>除了其核心手术平台外，直觉还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，胜过直觉外科</li>
<li>维京航运（Viking）创下历史新高——基本面信号显示未来还有更多</li>
<li>数据库（Datavalut）获得关注：现在卖出的五个理由</li>
<li>TMC 股票：为什么这家尚未盈利的矿业公司值得关注</li>
<li>电网正在衰退——是时候购买其替代品了吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
<p>在考虑直觉外科之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而直觉外科并不在名单上。</p>
<p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

直觉外科

ISUL

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

<p>华尔街禅将直觉外科（NASDAQ:ISRG）的评级从 “持有” 上调至 “买入”。其他分析师的意见各不相同，Evercore 将其目标价下调至 480 美元，而巴克莱则将其目标价设定为 651 美元。该股票目前的平均评级为 “适度买入”，共识目标价为 581.91 美元。直觉外科报告每股收益为 2.50 美元，超出预期，收入同比增长 23%</p>

<p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note issued to investors on Saturday.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）在华尔街 Zen 的股票研究分析师的研究报告中，将其评级从 “持有” 上调至 “买入”。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Intuitive Surgical</strong> 的提醒：</p>
</div><ul>
<li>Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>Intuitive Surgical 的抛售为 30% 的反弹机会铺平了道路</li>
</ul>
</div><p>A number of other analysts have also recently issued reports on ISRG. Evercore reduced their price objective on Intuitive Surgical from $550.00 to $480.00 and set a &#34;neutral&#34; rating for the company in a research report on Monday, April 6th. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an &#34;overweight&#34; rating in a research report on Thursday, April 23rd. Robert W. Baird raised their target price on Intuitive Surgical from $575.00 to $610.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday, April 22nd. Jefferies Financial Group cut their target price on Intuitive Surgical from $560.00 to $515.00 and set a &#34;hold&#34; rating on the stock in a report on Wednesday, April 22nd. Finally, BTIG Research restated a &#34;buy&#34; rating and set a $574.00 target price on shares of Intuitive Surgical in a report on Wednesday, April 22nd. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $581.91.</p>
<div class="lb-trans"><p>其他一些分析师最近也对 ISRG 发布了报告。Evercore 将 Intuitive Surgical 的目标价从 550.00 美元下调至 480.00 美元，并在 4 月 6 日的研究报告中给予该公司 “中性” 评级。Barclays 在 4 月 23 日的研究报告中将 Intuitive Surgical 的目标价设定为 651.00 美元，并给予该公司 “增持” 评级。Robert W. Baird 在 4 月 22 日的报告中将 Intuitive Surgical 的目标价从 575.00 美元上调至 610.00 美元，并给予该公司 “跑赢大盘” 评级。Jefferies Financial Group 在 4 月 22 日的报告中将 Intuitive Surgical 的目标价从 560.00 美元下调至 515.00 美元，并对该股票给予 “持有” 评级。最后，BTIG Research 在 4 月 22 日的报告中重申了 “买入” 评级，并将 Intuitive Surgical 的目标价设定为 574.00 美元。共有 18 位股票研究分析师对该股票给予了买入评级，7 位给予了持有评级，1 位给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 581.91 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Intuitive Surgical 的最新股票报告</strong></p>
</div><h2>Intuitive Surgical Trading Down 1.6%</h2>
<div class="lb-trans"><h2>Intuitive Surgical 股价下跌 1.6%</h2>
</div><ul>
<li>5 Stocks Racing Ahead as AI Supercharges Robotics</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只股票在 AI 超级推动下快速上涨</li>
</ul>
</div><p>ISRG opened at $421.12 on Friday. The stock has a market cap of $149.14 billion, a price-to-earnings ratio of 51.04, a PEG ratio of 3.42 and a beta of 1.51. Intuitive Surgical has a 1 year low of $417.74 and a 1 year high of $603.88. The stock has a fifty day moving average price of $463.63 and a 200 day moving average price of $514.04.</p>
<div class="lb-trans"><p>ISRG 周五开盘价为 421.12 美元。该股票的市值为 1491.4 亿美元，市盈率为 51.04，PEG 比率为 3.42，贝塔系数为 1.51。Intuitive Surgical 的一年低点为 417.74 美元，一年高点为 603.88 美元。该股票的 50 日移动平均价格为 463.63 美元，200 日移动平均价格为 514.04 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to analysts' expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business's revenue for the quarter was up 23.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.81 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical will post 8.57 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近于 4 月 21 日发布了季度财报。该医疗设备提供商报告每股收益（EPS）为 2.50 美元，超出分析师共识预期的 2.08 美元，超出幅度为 0.42 美元。该公司在本季度的收入为 27.7 亿美元，而分析师预期为 26.2 亿美元。Intuitive Surgical 的股本回报率为 15.98%，净利润率为 28.15%。该公司的季度收入同比增长 23.0%。去年同期，该公司每股收益为 1.81 美元。作为一个整体，卖方分析师预测 Intuitive Surgical 在当前财政年度将发布 8.57 美元的每股收益。</p>
</div><h2>Insider Activity at Intuitive Surgical</h2>
<div class="lb-trans"><h2>Intuitive Surgical 的内部活动</h2>
</div><ul>
<li>Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>超越生物技术——3 只适合成长型投资者的医疗股票</li>
</ul>
</div><p>In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the firm's stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the transaction, the executive vice president directly owned 6,120 shares in the company, valued at $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 2,362 shares of the firm's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president owned 3,554 shares in the company, valued at approximately $1,772,308.72. This trade represents a 39.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 5,647 shares of company stock valued at $2,760,359. Insiders own 0.60% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Intuitive Surgical 的新闻中，执行副总裁 Gary Loeb 于 5 月 11 日星期一出售了 400 股该公司的股票。股票以平均价格 446.95 美元出售，总交易额为 178,780.00 美元。交易后，该执行副总裁直接持有该公司 6,120 股，价值 2,735,334 美元。此交易代表其持股比例减少了 6.13%。该交易已在证券交易委员会的备案中披露，相关信息可在 SEC 网站上查阅。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，资深副总裁 Mark Brosius 于 3 月 4 日星期三出售了 2,362 股该公司的股票。股票以平均价格 498.68 美元出售，总价值为 1,177,882.16 美元。交易后，资深副总裁持有该公司 3,554 股，价值约 1,772,308.72 美元。此交易代表其持股比例减少了 39.93%。有关此销售的更多详细信息可在官方 SEC 披露中找到。在过去一个季度中，内部人士出售了价值 2,760,359 美元的 5,647 股公司股票。内部人士持有该公司股票的 0.60%。</p>
</div><h2>Hedge Funds Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>对 Intuitive Surgical 的对冲基金看法</h2>
</div><p>A number of institutional investors have recently made changes to their positions in the business. Gateway Wealth Partners LLC bought a new position in shares of Intuitive Surgical in the first quarter worth about $409,000. Blue Chip Partners LLC increased its stake in shares of Intuitive Surgical by 6.0% in the first quarter. Blue Chip Partners LLC now owns 2,274 shares of the medical equipment provider's stock worth $1,048,000 after purchasing an additional 129 shares during the period. Weiss Asset Management LP bought a new position in shares of Intuitive Surgical in the first quarter worth about $5,808,000. OMERS ADMINISTRATION Corp increased its stake in shares of Intuitive Surgical by 98.4% in the first quarter. OMERS ADMINISTRATION Corp now owns 289,024 shares of the medical equipment provider's stock worth $133,237,000 after purchasing an additional 143,345 shares during the period. Finally, Bradley Foster &amp; Sargent Inc. CT increased its stake in shares of Intuitive Surgical by 3.7% in the first quarter. Bradley Foster &amp; Sargent Inc. CT now owns 50,697 shares of the medical equipment provider's stock worth $23,371,000 after purchasing an additional 1,797 shares during the period. 83.64% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者最近对该公司的持仓进行了调整。Gateway Wealth Partners LLC 在第一季度购买了 Intuitive Surgical 的新股份，价值约 409,000 美元。Blue Chip Partners LLC 在第一季度将其在 Intuitive Surgical 的股份增加了 6.0%。Blue Chip Partners LLC 目前持有该医疗设备提供商的 2,274 股股票，价值 1,048,000 美元，此前在该期间内又购买了 129 股。Weiss Asset Management LP 在第一季度购买了 Intuitive Surgical 的新股份，价值约 5,808,000 美元。OMERS ADMINISTRATION Corp 在第一季度将其在 Intuitive Surgical 的股份增加了 98.4%。OMERS ADMINISTRATION Corp 目前持有该医疗设备提供商的 289,024 股股票，价值 133,237,000 美元，此前在该期间内又购买了 143,345 股。最后，Bradley Foster &amp; Sargent Inc. CT 在第一季度将其在 Intuitive Surgical 的股份增加了 3.7%。Bradley Foster &amp; Sargent Inc. CT 目前持有该医疗设备提供商的 50,697 股股票，价值 23,371,000 美元，此前在该期间内又购买了 1,797 股。83.64% 的股票目前由机构投资者持有。</p>
</div><h2>Key Stories Impacting Intuitive Surgical</h2>
<div class="lb-trans"><h2>影响 Intuitive Surgical 的关键故事</h2>
</div><p>Here are the key news stories impacting Intuitive Surgical this week:</p>
<div class="lb-trans"><p>以下是本周影响 Intuitive Surgical 的关键新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Multiple recent articles highlighted Intuitive Surgical as a potential beneficiary of the AI boom in healthcare, arguing that every robotic procedure creates valuable data that can improve surgeon training, intraoperative guidance, and predictive analytics. Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom</li>
<li>Positive Sentiment: Analysts at Erste Group Bank nudged up their FY2026 and FY2027 earnings estimates for ISRG, reinforcing expectations that earnings growth can continue above consensus. MarketBeat ISRG coverage</li>
<li>Positive Sentiment: Coverage around da Vinci 5 pointed to strong procedure growth and higher system utilization, suggesting the company’s newest platform is still gaining traction with surgeons and hospitals. Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?</li>
<li>Neutral Sentiment: Several bullish opinion pieces said the recent selloff has made Intuitive Surgical look more attractive to growth investors, but these were mostly commentary rather than new company-specific catalysts. Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It's Time to Buy.</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：多篇近期文章强调了直觉外科（Intuitive Surgical）作为医疗保健领域人工智能浪潮的潜在受益者，认为每一次机器人手术都会产生有价值的数据，从而改善外科医生培训、术中指导和预测分析。手术机器人与人工智能的结合：直觉外科、美敦力（Medtronic）和史崔克（Stryker）是医疗保健繁荣的潜在黑马。</li>
<li>积极情绪：Erste Group Bank 的分析师上调了对 ISRG 的 2026 财年和 2027 财年的盈利预期，强化了盈利增长能够持续超过市场共识的预期。MarketBeat 对 ISRG 的覆盖。</li>
<li>积极情绪：关于达芬奇 5（da Vinci 5）的报道指出手术增长强劲，系统利用率提高，表明该公司的最新平台仍在外科医生和医院中获得认可。ISRG 的达芬奇 5 能否维持手术和利用率的增长？</li>
<li>中性情绪：几篇乐观的评论文章表示，近期的抛售使得直觉外科对成长型投资者更具吸引力，但这些主要是评论而非新的公司特定催化剂。直觉外科今年已下跌 20%。华尔街表示，现在是买入的时机。</li>
</ul>
</div><h2>Intuitive Surgical Company Profile</h2>
<div class="lb-trans"><h2>直觉外科公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.</p>
<div class="lb-trans"><p>直觉外科成立于 1995 年，总部位于加利福尼亚州阳光谷，是一家专注于设计、制造和服务机器人辅助手术系统的医疗技术公司。该公司以其达芬奇手术系统而闻名，该系统通过将外科医生的手部动作转化为患者体内小型仪器的更精细、缩放的运动，从而实现微创手术。直觉的业务集中在向医院和手术中心提供系统、仪器及相关技术，旨在提高手术室的精确度、可视化和控制能力。</p>
</div><p>In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.</p>
<div class="lb-trans"><p>除了其核心手术平台外，直觉还销售一系列可重复使用和一次性使用的仪器、配件和专有软件，并为客户提供培训、服务和临床支持。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Viking Sails to All-Time Highs—Fundamentals Signal More to Come</li>
<li>Datavalut Gains Traction: 5 Reasons to Sell Now</li>
<li>TMC Stock: Why This Pre-Revenue Miner Is Worth Watching</li>
<li>The Power Grid Is Dying—Is It Time to Buy Its Replacement?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过直觉外科</li>
<li>维京航运（Viking）创下历史新高——基本面信号显示未来还有更多</li>
<li>数据库（Datavalut）获得关注：现在卖出的五个理由</li>
<li>TMC 股票：为什么这家尚未盈利的矿业公司值得关注</li>
<li>电网正在衰退——是时候购买其替代品了吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑直觉外科之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而直觉外科并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

直觉外科（NASDAQ 代码：ISRG）被华尔街 Zen 升级为买入评级